Published articles

Published articles 2 records found  Search took 0.02 seconds. 
1.
16 p, 1.3 MB Wharton's jelly mesenchymal stromal cells and derived extracellular vesicles as post-myocardial infarction therapeutic toolkit : an experienced view / Muñoz-Domínguez, Noelia (Banc de Sang i Teixits) ; Roura, Santiago (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Prat-Vidal, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vives Armengol, Joaquim (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Outstanding progress has been achieved in developing therapeutic options for reasonably alleviating symptoms and prolonging the lifespan of patients suffering from myocardial infarction (MI). Current treatments, however, only partially address the functional recovery of post-infarcted myocardium, which is in fact the major goal for effective primary care. [...]
2021 - 10.3390/pharmaceutics13091336
Pharmaceutics, Vol. 13 Núm. 9 (september 2021) , p. 1336  
2.
16 p, 1.4 MB Modulation of colorectal tumor behavior via lncRNA TP53TG1-lipidic nanosystem / Masoumi, Farimah (Islamic Azad University) ; Saraiva, Sofia M. (Centro de Investigación Biomédica en Red de Cáncer) ; Bouzo, Belén L. (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; López-López, Rafael (Instituto de Investigación Sanitaria de Santiago (IDIS)) ; Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Diaz-Lagares, Angel (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ; de la Fuente, María (Centro de Investigación Biomédica en Red de Cáncer)
Long non-coding RNAs (lncRNAs) are an emerging group of RNAs with a crucial role in cancer pathogenesis. In gastrointestinal cancers, TP53 target 1 (TP53TG1) is an epigenetically regulated lncRNA that represents a promising therapeutic target due to its tumor suppressor properties regulating the p53-mediated DNA damage and the intracellular localization of the oncogenic YBX1 protein. [...]
2021 - 10.3390/pharmaceutics13091507
Pharmaceutics, Vol. 13 Núm. 9 (september 2021) , art. 1507  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.